United States Cardiovascular Devices Market Size (2024 - 2029)

The United States cardiovascular devices market is anticipated to experience growth driven by factors such as an established healthcare infrastructure, technological advancements, and an increasing prevalence of cardiovascular diseases. The market size is influenced by the demand for minimally invasive procedures and the rising incidence of conditions like heart valve disease, particularly among the aging population. Although the COVID-19 pandemic temporarily disrupted production and delayed procedures, the ongoing developments in cardiovascular technology are expected to support the market's expansion.

Home Market Analysis Healthcare Research Device Drug Combination Research Diagnostics and Therapeutics Research Cardiovascular Research United States Cardiovascular Devices Market Market Size

Market Size of United States Cardiovascular Devices Industry

US Cardiovascular Devices Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 7.80 %

Major Players

US Cardiovascular Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

USA Cardiovascular Devices Market Analysis

The United States Cardiovascular Devices Market is expected to register a CAGR of 4.8% during the forecast period.

The COVID-19 pandemic impacted the production of cardiovascular devices in United States in the year 2020. Furthermore, the delay of elective procedures due to COVID-19-related measures has adversely affected the cardiovascular medical devices market, especially in 2020. While some cardiovascular procedures are considered urgent, others have been postponed and delayed since the beginning of the global pandemic. Hence, lifestyle changes and medication can be temporarily prescribed instead of cardiovascular procedures for some patients. Another factor negatively impacting the market is the reduction in the diagnosis of cardiovascular diseases due to healthcare resources being reserved for COVID-19 patients.

The major factors driving the growth of the market in the United States are the presence of established healthcare infrastructure, rapid technological advancements, increasing burden of cardiovascular diseases, and increased adoption of minimally invasive procedures.

As per Heart Disease & Stroke Statistical Fact Sheet 2020, estimates that a minimum of 40,000 infants is expected to be affected each year by congenital heart defects in the United States. Of these, about 25% or 2.4 (per 1,000 live births), require treatment in the first year of life. In addition, according to the Centers for Disease Control and Prevention (CDC), in the United States, the prevalence of atrial fibrillation is estimated to rise to 12.1 million by the year 2030.

In 2021, every year, 5 million Americans are diagnosed with HVD (heart valve disease), according to the American College of Cardiology. Because of calcium buildup and scarring in the valve cusp, HVD primarily affects the elderly. As a result, the rapidly aging population and the resulting increase in VHD (Valvular heart disease) are increasing demand for prosthetic heart valves in the United States.

Furthermore, due to ongoing development in the cardiovascular field and technological advancements are also expected to propel the growth of the United States cardiovascular devices market.

USA Cardiovascular Devices Industry Segmentation

As per the scope of the report, Cardiovascular diseases are a group of disorders of the heart and blood vessels that includes coronary heart disease, peripheral arterial disease, congenital heart disease, and cerebrovascular disease. Cardiovascular devices are used to treat or prevent different cardiovascular conditions. The United States cardiovascular devices market is segmented by device type (Diagnostic and Monitoring Devices and Therapeutic and Surgical Devices). 

By Device Type
Diagnostic and Monitoring Devices
Electrocardiogram (ECG)
Remote Cardiac Monitoring
Other Diagnostic and Monitoring Devices
Therapeutic and Surgical Devices
Cardiac Assist Devices
Cardiac Rhythm Management Device
Catheter
Grafts
Heart Valves
Stents
Other Therapeutic and Surgical Devices
Need A Different Region Or Segment?
Customize Now

United States Cardiovascular Devices Market Size Summary

The United States cardiovascular devices market is poised for steady growth, driven by a combination of established healthcare infrastructure, rapid technological advancements, and an increasing burden of cardiovascular diseases. The market experienced disruptions due to the COVID-19 pandemic, which led to delays in elective procedures and a temporary shift towards lifestyle changes and medication over surgical interventions. However, the demand for cardiovascular devices is expected to rise, fueled by the growing prevalence of conditions such as heart valve disease and atrial fibrillation, particularly among the aging population. Technological innovations, such as portable and wireless electrocardiograms, are enhancing the ability to monitor and diagnose heart conditions remotely, further propelling market expansion.

The competitive landscape of the United States cardiovascular devices market is characterized by the presence of major players like Abbott Laboratories, Boston Scientific Corporation, and Medtronic PLC, among others. These companies are actively engaging in strategic partnerships and acquisitions to enhance their product offerings and market reach. For instance, the partnership between Myocardial Solutions, Inc. and United Imaging, Inc. aims to integrate cardiac and cancer care solutions, highlighting the ongoing development in the field. Regulatory approvals, such as the FDA's endorsement of non-surgical heart valves, and the introduction of innovative technologies like Boston Scientific's DIRECTSENSE, are expected to drive market growth. The increasing incidence of cardiovascular diseases and the rising demand for minimally invasive procedures are key factors that will continue to shape the market dynamics in the coming years.

Explore More

United States Cardiovascular Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rapid Technological Advancements

      2. 1.2.2 Increasing Burden of Cardiovascular Diseases

      3. 1.2.3 Increased Preference of Minimally Invasive Procedures

    3. 1.3 Market Restraints

      1. 1.3.1 Stringent Regulatory Policies

      2. 1.3.2 High Cost of Instruments and Procedures

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Device Type

      1. 2.1.1 Diagnostic and Monitoring Devices

        1. 2.1.1.1 Electrocardiogram (ECG)

        2. 2.1.1.2 Remote Cardiac Monitoring

        3. 2.1.1.3 Other Diagnostic and Monitoring Devices

      2. 2.1.2 Therapeutic and Surgical Devices

        1. 2.1.2.1 Cardiac Assist Devices

        2. 2.1.2.2 Cardiac Rhythm Management Device

        3. 2.1.2.3 Catheter

        4. 2.1.2.4 Grafts

        5. 2.1.2.5 Heart Valves

        6. 2.1.2.6 Stents

        7. 2.1.2.7 Other Therapeutic and Surgical Devices

United States Cardiovascular Devices Market Size FAQs

The United States Cardiovascular Devices Market is projected to register a CAGR of 7.80% during the forecast period (2024-2029)

Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences, Medtronic PLC and Cardinal Health Inc. are the major companies operating in the United States Cardiovascular Devices Market.

United States Cardiovascular Devices Report Snapshots

United States Cardiovascular Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)